203 related articles for article (PubMed ID: 37203073)
21. Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series.
Furer V; Zisman D; Kibari A; Rimar D; Paran Y; Elkayam O
Rheumatology (Oxford); 2021 Oct; 60(SI):SI90-SI95. PubMed ID: 33848321
[TBL] [Abstract][Full Text] [Related]
22. Distinguishing Features of Anterior Uveitis Caused by Herpes Simplex Virus, Varicella-Zoster Virus, and Cytomegalovirus.
Terada Y; Kaburaki T; Takase H; Goto H; Nakano S; Inoue Y; Maruyama K; Miyata K; Namba K; Sonoda KH; Kaneko Y; Numaga J; Fukushima M; Horiguchi N; Ide M; Ehara F; Miyazaki D; Hasegawa E; Mochizuki M
Am J Ophthalmol; 2021 Jul; 227():191-200. PubMed ID: 33773985
[TBL] [Abstract][Full Text] [Related]
23. Varicella zoster virus reactivation following COVID-19 vaccination: a report of 3 cases.
Saraiva AL; Vieira AR; Marinho MC; Zadorozhnya O
Fam Pract; 2022 Sep; 39(5):939-942. PubMed ID: 35244157
[TBL] [Abstract][Full Text] [Related]
24. Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination.
Naseri A; Good WV; Cunningham ET
Am J Ophthalmol; 2003 Mar; 135(3):415-7. PubMed ID: 12614776
[TBL] [Abstract][Full Text] [Related]
25. Keratitis in association with herpes zoster and varicella vaccines.
Grillo AP; Fraunfelder FW
Drugs Today (Barc); 2017 Jul; 53(7):393-397. PubMed ID: 28837183
[TBL] [Abstract][Full Text] [Related]
26. Commentary on "Potential risk factors for Varicella-zoster virus reactivation after COVID-19 vaccination".
Turkmen D; Altunisik N; Altunisik Toplu S
J Cosmet Dermatol; 2022 Aug; 21(8):3627-3628. PubMed ID: 35390221
[No Abstract] [Full Text] [Related]
27. The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus.
Maldonado MD; Romero-Aibar J
Brain Behav Immun Health; 2021 Dec; 18():100381. PubMed ID: 34746880
[TBL] [Abstract][Full Text] [Related]
28. Viral reactivation following COVID-19 vaccination: a review of the current literature.
Martora F; Megna M; Battista T; Scalvenzi M; Villani A; Cacciapuoti S; Potestio L
Clin Exp Dermatol; 2024 May; 49(6):556-565. PubMed ID: 38374769
[TBL] [Abstract][Full Text] [Related]
29. Varicella zoster meningitis following COVID-19 vaccination: a report of two cases.
Buranasakda M; Kotruchin P; Phanthachai K; Mootsikapun P; Chetchotisakd P
Int J Infect Dis; 2022 Jun; 119():214-216. PubMed ID: 35367355
[TBL] [Abstract][Full Text] [Related]
30. Multiple ocular manifestations in a patient diagnosed with herpes zoster ophthalmicus: case report.
Beuran DI; Macovei ML; Boca IR
Rom J Ophthalmol; 2024; 68(1):81-86. PubMed ID: 38617727
[No Abstract] [Full Text] [Related]
31. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
[TBL] [Abstract][Full Text] [Related]
32. A narrative review and clinical anatomy of herpes zoster infection following COVID-19 vaccination.
Iwanaga J; Fukuoka H; Fukuoka N; Yutori H; Ibaragi S; Tubbs RS
Clin Anat; 2022 Jan; 35(1):45-51. PubMed ID: 34554601
[TBL] [Abstract][Full Text] [Related]
33. Comparison of rubella virus- and herpes virus-associated anterior uveitis: clinical manifestations and visual prognosis.
Wensing B; Relvas LM; Caspers LE; Valentincic NV; Stunf S; de Groot-Mijnes JD; Rothova A
Ophthalmology; 2011 Oct; 118(10):1905-10. PubMed ID: 21764137
[TBL] [Abstract][Full Text] [Related]
34. Review for Disease of the Year: Varicella Zoster Virus-Induced Anterior Uveitis.
Tugal-Tutkun I; Cimino L; Akova YA
Ocul Immunol Inflamm; 2018; 26(2):171-177. PubMed ID: 29023181
[TBL] [Abstract][Full Text] [Related]
35. A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient.
Maruki T; Ishikane M; Suzuki T; Ujiie M; Katano H; Ohmagari N
Int J Infect Dis; 2021 Dec; 113():55-57. PubMed ID: 34587536
[TBL] [Abstract][Full Text] [Related]
36. Ocular findings in Japanese patients with varicella-zoster virus infection.
Yoshida M; Hayasaka S; Yamada T; Yanagisawa S; Hayasaka Y; Nakamura N; Mihara M
Ophthalmologica; 2005; 219(5):272-5. PubMed ID: 16123552
[TBL] [Abstract][Full Text] [Related]
37. Detection of varicella zoster virus DNA and viral antigen in human cornea after herpes zoster ophthalmicus.
Wenkel H; Rummelt C; Rummelt V; Jahn G; Fleckenstein B; Naumann GO
Cornea; 1993 Mar; 12(2):131-7. PubMed ID: 8388787
[TBL] [Abstract][Full Text] [Related]
38. Herpes zoster after COVID vaccination.
van Dam CS; Lede I; Schaar J; Al-Dulaimy M; Rösken R; Smits M
Int J Infect Dis; 2021 Oct; 111():169-171. PubMed ID: 34428545
[TBL] [Abstract][Full Text] [Related]
39. Coin-shaped corneal endothelial scar in herpes zoster ophthalmicus: a case report.
Lee SH; Chun YS; Kim KW
J Med Case Rep; 2022 Mar; 16(1):107. PubMed ID: 35296348
[TBL] [Abstract][Full Text] [Related]
40. Herpes Zoster Following COVID-19 Vaccine Booster.
Shahrudin MS; Mohamed-Yassin MS; Nik Mohd Nasir NM
Am J Case Rep; 2023 Jan; 24():e938667. PubMed ID: 36650730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
